Skip to Content
πŸ’‰ Sedated LAB Rats πŸ€
Today’s Change
β€”

A symphony is an automated trading strategy β€” Learn more about symphonies here

About

Core: ride strong trends in AI chipmakers and obesity/diabetes drug leaders, overweighting recent winners. Tactical sleeve: make fast, leveraged bets in biotech, tech, or volatility using simple β€œtoo hot/too cold” signals. Very aggressive; rebalanced daily.
NutHow it works
Most money rides winners in AI chips (NVDA, AMD, SMCI, KLAC) and obesity/diabetes drugs (LLY, NVO). It then adds extra weight to the hottest recent performer. If markets get too hot, it briefly bets on a volatility pop (UVXY). If tech looks washed out, it buys 3x tech (TECL). Otherwise it flips 3x biotech bull/bear (LABU/LABD) based on whether bonds are stronger than riskier stocks.
CheckmarkValue prop
Capitalize on AI/GLP-1 momentum with a risk-managed core+tactical approach. OOS Sharpe ~0.42 across 646 days, plus hedges and fast theme bets, delivering diversification and growth potential to complement the S&P in tech/biotech cycles.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
Alpha
Beta
R2
R
0.75
1.12
0.15
0.39
Performance Metrics
Cumulative Return
Annualized Return
Trailing 1M Return
Trailing 3M Return
Sharpe Ratio
271.39%
13.36%
-1.67%
2.89%
0.79
321,086.23%
116.33%
-1.05%
5.23%
1.74
Initial Investment
$10,000.00
Final Value
$32,118,623.39
Regulatory Fees
$75,098.38
Total Slippage
$519,696.48
Invest in this strategy
OOS Start Date
Feb 5, 2024
Trading Setting
Daily
Type
Stocks
Category
Momentum, tactical allocation, leveraged etfs, biotech, semiconductors, pharmaceuticals, volatility, daily rebalanced, high risk
Tickers in this symphonyThis symphony trades 0 assets in total
Ticker
Type